Viatris (VTRS) shares outstanding: 1.15B
Viatris had 1.15B shares outstanding on Nov 2, 2026, down 0.5% from 1.15B a year earlier.
From Viatris's filings with the SEC · VTRS stock page
Viatris shares outstanding by year
#87 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Nov 2, 2026 | 1.15B | -0% |
| Nov 3, 2025 | 1.15B | -4% |
| Nov 4, 2024 | 1.19B | -1% |
| Nov 2, 2023 | 1.20B | -1% |
| Nov 2, 2022 | 1.21B | – |
Shares outstanding of similar companies
Companies in the same industry as Viatris, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Abbott Laboratories | 1.73B | Sep 30, 2026 |
| BeOne Medicines | 1.48B | Oct 30, 2026 |
| TEVA Pharmaceutical Industries | 1.17B | Sep 30, 2026 |
| Viatris | 1.15B | Nov 2, 2026 |
| Eli Lilly | 940.7M | Oct 26, 2026 |
| HUTCHMED (China) | 872.3M | Dec 31, 2025 |
| Summit Therapeutics | 799.8M | Oct 30, 2026 |
Questions and answers
What is Viatris's shares outstanding?
Viatris had 1.15B shares outstanding on Nov 2, 2026, down 0.5% from 1.15B a year earlier.
Numbers as reported in Viatris's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology